title: Blockbuster drugs coming off patent: will cap contracts benefit?
abstract: Health care organizations and PBMs continue to struggle to find ways to contain prescription drug expenditures, but upcoming patent expirations on blockbuster drugs may help the bottom line.
mesh_terms: D002204:Capitation Fee; D017046:Cost Savings / Q000379:methods; D011307:Drug Prescriptions / Q000191:economics*; D006279:Health Maintenance Organizations / Q000191:economics* / Q000458:organization & administration; D010330:Patents as Topic; D014481:United States